Interestingly, we also identified copy number gains or amplifications in PRKAA1, encoding AMPKα1, suggesting that there may be compensatory mechanisms to upregulate AMPK activity in late-stage ovarian tumours harbouring reduced LKB1 in order to maintain a functional pathway for tumour cell survival during metastasis. The gene discussed is PRKAA1; the disease is ovarian neoplasm.